Duality Advisers, LP Amicus Therapeutics, Inc. Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$11.43 - $14.24 $123,352 - $153,678	10,792 Added 40.32%	37,555 $442,000
Q4 2023 Feb 01, 2024	BUY	$9.97 - $14.52 $95,901 - $139,667	9,619 Added 56.11%	26,763 $379,000
Q3 2023 Nov 02, 2023	BUY	$11.78 - $13.86 $201,956 - $237,615	17,144 New	17,144 $208,000
Q1 2023 Jun 27, 2023	BUY	$10.91 - $13.54 $183,648 - $227,918	16,833 Added 21.57%	94,890 $1.05 Million
Q4 2022 Feb 07, 2023	SELL	$9.89 - $12.7 $1.05 Million - $1.35 Million	-106,530 Reduced 57.71%	78,057 $953,000
Q3 2022 Nov 03, 2022	BUY	$9.82 - $12.75 $1.81 Million - $2.35 Million	184,587 New	184,587 $1.93 Million

312

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.64B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.